4//SEC Filing
MALKIEL BURTON G 4
Accession 0001179110-17-011478
CIK 0001583107other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 7:57 PM ET
Size
6.9 KB
Accession
0001179110-17-011478
Insider Transaction Report
Form 4
MALKIEL BURTON G
Director
Transactions
- Purchase
Ordinary Shares
2017-08-11$24.59/sh+15,000$368,855→ 47,571 total - Purchase
Ordinary Shares
2017-08-11$24.59/sh+15,000$368,816→ 15,000 total(indirect: By Spouse)
Footnotes (2)
- [F1]Represents the weighted average purchase price per share for the open market purchase on August 11, 2017. The shares were purchased at prices ranging from $24.35 to $24.921 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F2]Represents the weighted average purchase price per share for the open market purchase on August 11, 2017. The shares were purchased at prices ranging from $24.36 to $24.903 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001184677
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 7:57 PM ET
- Size
- 6.9 KB